Company profile: Cardio Diagnostics
1.1 - Company Overview
Company description
- Provider of clinical tests and services for heart disease prevention and early detection, including Epi+Gen CHD, which combines genetic and epigenetic DNA biomarkers with AI to assess near-term coronary heart disease risk and deliver personalized insights; HeartRisk for data-driven collaborations among stakeholders; and PrecisionCHD to shift from treatment to prevention using epigenetics and AI.
Products and services
- Epi+Gen CHD: Clinical test combining genetic and epigenetic DNA biomarkers with AI analysis to assess near-term coronary heart disease risk and deliver personalized prevention insights
- PrecisionCHD: AI-enabled service using epigenetics to transform the heart disease approach from treatment-based to prevention-based, prioritizing prevention in care
- HeartRisk: Data-driven service facilitating collaborations among various stakeholders to drive results in heart disease prevention and intervention
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cardio Diagnostics
Self Care Catalysts
HQ: Canada
Website
- Description: Provider of patient informatics solutions and the Health Storylines digital platform that supports patient engagement, continuous monitoring, and care coordination via a patient app and practitioner tool; real-world, longitudinal data collection with wearable integration; virtual health/telehealth; strong patient data privacy and control; and community-science collaboration to inform care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Self Care Catalysts company profile →
Cardioline
HQ: Italy
Website
- Description: Provider of ECG management, Holter monitoring, and stress testing solutions, including ECGWebApp web-based ECG management; Walkfree cable-free Holter patch recorder; CubeStress stress exercise testing platform; CubeHolter web-based Holter monitoring; touchECG Bluetooth digital ECG for Windows and Android; and ECG Series electrocardiographs. Located in Milan.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardioline company profile →
CarePort
HQ: United States
Website
- Description: Provider of an online booking engine and software solutions that identify and connect patients with high-quality post-acute care providers, support discharge decision-making, and manage referrals. Offerings include patient event notifications (admissions, transfers, discharges), referral management, intake for post-acute providers, referrals to community-based organizations, and patient tracking across the care continuum.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CarePort company profile →
Prognos Health
HQ: United States
Website
- Description: Provider of a healthcare analytics platform (prognosFACTOR) that queries billions of lab and health records on 325M de-identified patients to deliver clinical insights in minutes. Offerings include Prognos Marketplace for identifying and purchasing patient-centric data, Prognos Factor for data-driven decisions, Commercial Analytics to optimize brand strategy, and Precision Marketing using real-world data for HCP outreach.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prognos Health company profile →
naviHealth
HQ: United States
Website
- Description: Provider of post-acute care management services and technology to improve outcomes and reduce costs, partnering with health plans, health systems, and post-acute providers to manage the post-acute continuum. Offerings include care transitions technology, discharge planning and referral software, smart-touch/smart-tech care management, social determinants of health solutions, and risk-based population management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full naviHealth company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cardio Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cardio Diagnostics
2.2 - Growth funds investing in similar companies to Cardio Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cardio Diagnostics
4.2 - Public trading comparable groups for Cardio Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →